IBRX
ImmunityBio, Inc. Common Stock
$7.58
25.75%
+1.55
Notify me if price changes either direction
Buy IBRX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
5.9B
Enterprise value
6.5B
Trailing PE
-12.85593220339
Forward PE
-23.551252
PEG Ratio
0.30854237288136
Enterprise to EBITDA
-26.373
Enterprise to revenue
78.251
Price to book MRQ
-13.717675598479
Price to sales TTM
72.1218
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
82.6M
EBITDA
-244947008
Diluted EPS TTM
-0.41
Total Cash (MRQ)
257.8M
Current ratio (MRQ)
5.767
Operating Cash Flow (TTM)
-319702016
IBRX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
February 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
